Earnings Ahead

ABT - Abbott

115.93 -1.2 -1.03

Abbott

Abbott

About

Profile

We create breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help you, your family and your community lead healthier lives, full of unlimited possibilities. Today, 103,000 of us are working to


Headquarters

Chicago, Illinois, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ABT

Shares of the biotech company rose 5% after a jury in Missouri cleared Abbott of liability in a baby formula case. There are still other similar cases pending against Abbott.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Abbott Q2 results top consensus as base business offsets COVID impact
  • Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M
  • Abbott seen reporting lower Q2 revenue, due in part to less COVID testing
  • Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
  • Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
  • Goldman Sachs sees rays of hope in underperforming health sector
  • BTIG unveils top picks for rest of '23: D.R. Horton, CrowdStrike, DraftKings among names
  • FDA approves Abbott dual-chamber leadless pacemaker Aveir DR
  • Medicare revises guidance on drug price negotiations amid lawsuits
  • Abbott gains expanded coverage for glucose monitoring device in France
  • Abbott names Philip Boudreau CFO effective Sept. 1
  • Abbott Laboratories declares $0.51 dividend
  • Abbott alleges former scientist in its nutrition unit stole trade secrets
  • Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson
  • Abbott, IQVIA, Global Fund, partners commit $54M to boost laboratory system for pandemics
  • Abbott boasts of heart failure reduction data for CardioMEMS device
  • Abbott, other baby-formula makers see FTC probe over collusion - report
  • Abbott recalled baby formula claims tossed by federal judge
  • Abbott gains approval of TactiFlex ablation catheter treatment
  • Stereotaxis stock rises after pact with Abbott to improve abnormal heartbeat treatment
Date Price Open High Low Vol Change
Nov 20 115.93 116.69
116.74
115.54
3.6M -1.02%
Nov 19 117.13 116.91
117.55
115.45
4.5M -0.2%
Nov 18 117.36 115.57
117.94
115.51
6.1M 1.26%
Nov 15 115.9 114.87
116.35
114.43
6.9M 0.76%
Nov 14 115.03 115.98
116.09
114.93
3.8M -0.61%
 
Nov 13 115.74 116.08
116.81
115.55
4.8M -0.6%
Nov 12 116.44 116.68
117.3
116.42
4.6M -0.31%
Nov 11 116.8 116.94
117.84
116.33
5.3M 0.18%
Nov 8 116.59 115.33
117.25
114.69
5.7M 1.12%
Nov 7 115.3 117.49
117.49
114.54
5.5M -1.28%
Nov 6 116.8 121
121
115.5
5.3M -0.79%
Nov 5 117.73 117.59
118.25
116.33
4.1M 0.07%
Nov 4 117.65 119.6
120.57
117.48
5.6M -0.8%
Nov 1 118.6 119.75
119.92
117.09
10.1M 4.61%
Oct 31 113.37 113.57
114.47
113.27
5.3M -0.94%
Oct 30 114.45 112.64
114.74
112.5
5.2M 0.93%
Oct 29 113.4 114.14
114.74
113.35
4.5M -0.59%
Oct 28 114.07 114.77
114.83
113.55
4.1M -0.13%
Oct 25 114.22 116.14
116.39
113.2
6.0M -1.99%
Oct 24 116.54 117.21
117.41
116.21
3.8M -0.4%
Oct 23 117.01 116.16
117.15
115.93
3.7M 0.77%
Oct 22 116.12 116.86
117.2
115.84
5.4M -0.74%
Oct 21 116.99 118.89
118.92
116.6
8.3M -2.01%
Oct 18 119.39 117.9
119.85
117.67
6.7M 1.27%
Oct 17 117.89 118.71
118.76
117.19
5.0M 0.06%
Oct 16 117.82 118.01
119.52
116.64
7.4M 1.53%
Oct 15 116.05 116.75
118.36
115.81
6.5M -1.02%
Oct 14 117.25 116.26
117.58
115.98
3.7M 0.97%
Oct 11 116.12 116.21
117.28
115.94
3.5M 0.43%
Oct 10 115.62 116.21
116.85
115.45
4.1M -0.28%
Oct 9 115.95 114.98
116.27
114.56
4.3M 1.15%
Oct 8 114.63 113.75
115.29
113.75
4.3M 1.12%
Oct 7 113.36 112.3
113.61
111.8
6.9M 0.64%
Oct 4 112.64 112.13
112.75
111.68
4.4M 0.37%
Oct 3 112.23 113.5
113.51
111.79
3.5M -1.24%
Oct 2 113.64 113.38
113.79
112.03
3.5M 0.07%
Oct 1 113.56 114.21
114.22
112.8
4.3M -0.39%
Sep 30 114.01 112.57
114.09
112.1
5.0M 1.41%
Sep 27 112.43 112.93
113.38
112.32
3.6M -0.27%
Sep 26 112.73 112.31
112.93
112.1
3.5M 0.11%
Sep 25 112.61 113.82
114.19
111.85
5.2M -0.64%
Sep 24 113.34 114.21
114.41
113.18
5.0M -1.28%
Sep 23 114.81 113.79
114.9
112.96
5.0M 0.98%
Sep 20 113.7 113.75
114.16
113.2
8.4M -0.39%
Sep 19 114.15 115.49
115.66
113.25
8.1M -0.64%
Sep 18 114.88 117.5
117.5
114.52
6.0M -2.75%
Sep 17 118.13 117.8
118.54
117.26
5.0M 0.43%
Sep 16 117.63 117
117.68
116.42
3.6M 1.06%
Sep 13 116.4 116.02
117.05
115.94
3.4M -0.37%
Sep 12 116.83 116.5
117.31
115.59
4.3M 0.20%
Sep 11 116.6 116.39
116.72
114.72
6.5M -0.44%
Sep 10 117.11 116.15
117.25
115.43
5.0M 0.58%
Sep 9 116.43 114.46
116.73
114.32
5.1M 2.26%
Sep 6 113.86 113.63
114.34
113.01
3.8M 0.67%
Sep 5 113.1 114.26
114.48
112.52
2.9M -1.14%
Sep 4 114.4 114.69
115.59
113.57
3.7M -0.23%
Sep 3 114.66 113.36
114.83
113.36
4.4M 1.23%
Aug 30 113.27 113
113.47
111.89
4.3M 0.45%
Aug 29 112.76 113.29
113.5
112.52
3.4M -0.12%
Aug 28 112.9 113.1
113.42
112.37
3.8M 0%